Add Company
Join Now

Neuvivo Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Neuvivo's estimated annual revenue is currently $775k per year.(i)
  • Neuvivo's estimated revenue per employee is $77,500

Employee Data

  • Neuvivo has 10 Employees.(i)
  • Neuvivo grew their employee count by 11% last year.

Neuvivo's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief StaffReveal Email/Phone
3
Chief Medical Affairs OfficerReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
VP Program ManagementReveal Email/Phone
6
Head CommercializationReveal Email/Phone
7
VP ManufacturingReveal Email/Phone
8
Chief Scientific OfficerReveal Email/Phone
9
Chief Medical OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is Neuvivo?

Neuvivo is dedicated to creating therapeutics for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. We have developed a patented macrophage-targeted technology, NP001, that addresses chronic inflammation, a key factor in the progressive loss of motor function in ALS. NP001 has received Orphan Drug and Fast Track designation by the FDA as it addresses a clear unmet medical need. We are working to move this compound toward approval and delivering an effective and safe new treatment for ALS.

keywords:N/A

N/A

Total Funding

10

Number of Employees

$775k

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.2M10-37%N/A
#2
$1.2M10-41%N/A
#3
$0.9M10N/AN/A
#4
$1.5M10N/AN/A
#5
$0.9M10N/AN/A